Skip to content

Medical-device intelligence

NGA: Test, Follicle Stimulating Hormone (Fsh), Over The Counter

FDA product code NGA: Test, Follicle Stimulating Hormone (Fsh), Over The Counter. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
NGA
FDA device name
Test, Follicle Stimulating Hormone (Fsh), Over The Counter
Device class
1
Regulation number
862.1300
Medical specialty
Clinical Chemistry
Review panel
TX

The source does not provide a definition for this entry. Consult the FDA classification and regulation reference for further detail.

Explore clinical chemistry records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

2 clearance records and 2 recall records in the covered releases, across 4 source company names and 1 product codes. Dated history runs from Oct 30, 2003 to Nov 22, 2025.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202502
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

4 matching records
Device / recordCompany in FDA recordSourceSource date
Menopause Test Cassette (Urine)Z-1260-2026 · NGAChangchun Wancheng Bio-Electron Co., Ltd.RecallFeb 4, 2026FDA classification date
Menopause (FSH) 2 TestsZ-0744-2026 · NGAGET TESTED INTERNATIONAL ABRecallDec 1, 2025FDA classification date
QUANTRX FEMALE FERTILITY TESTK070484 · NGAQuantrx Biomedical Corporation510(k)Oct 22, 2007FDA decision date
FERTELL FEMALE FERTILITY TESTK032002 · NGAGenosis, Inc.510(k)Oct 30, 2003FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗